Insight
510(k) K811345
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK811345 | Date10 Jul 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GZJ
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.5890
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Insight is a Stimulator, Nerve, Transcutaneous, For Pain Relief, classified under FDA product code GZJ. This device delivers transcutaneous electrical nerve stimulation (TENS) to alleviate pain by modulating nerve signals through low-voltage electrical impulses applied to the skin.
Intended for clinical use in neurology settings, the Insight is supplied as a reusable medical device. It requires no sterility beyond standard electrical safety standards and is regulated under FDA 510(k) clearance (K811345) with a decision of Substantially Equivalent (SESE). No specific MRI safety or single-use requirements are noted in the regulatory filings.